Genentech-partnered Genesis Therapeutics inks newest AI discovery deal with Eli Lilly

A Stanford biotech rubbed elbows with Genentech in 2020, reaching a deal with the big-name biotech just over 18 months ago. And now, the AI outfit is in its second partnership with Big Pharma.

Genesis Therapeutics secured a deal with big pharma Eli Lilly, the company announced on...

Click to view original post